ABPO — Abpro Holdings, Inc.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1893219 ·
Last close
$0.36
Market Cap
$2.10M
52W High
$7.34
52W Low
$0.09
ADV30
19,344
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -1,175,000 | -940,000 | 5,241,000 | 4,236,000 | 8,225,000 |
| Mar 2026 | 0 | — | -933,000 | -1,028,000 | 6,865,000 | 5,398,000 | 9,117,000 |
| Dec 2025 | 0 | — | 2,504,000 | 5,636,000 | 1,063,000 | 67,000 | 9,345,000 |
| Sep 2025 | 0 | — | -1,336,000 | -1,657,000 | 1,703,000 | 328,000 | 17,298,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,583,000
Investing CF
$-29,638,990
Financing CF
$10,565,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.20
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-120,023,000
Inventory
—
Receivables
$183,000
ST Investments
—
EBIT TTM
$1,481,000
Pretax Income TTM
$-33,000
Interest Exp TTM
$1,514,000
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -4,051,000 | -2,892,000 | 1,063,000 | 9,345,000 | -8,831,000 | -6,006,000 |
| Dec 2024 | 183,000 | -9,921,000 | -7,232,000 | 4,661,000 | 19,607,000 | -15,495,000 | -9,030,000 |
| Dec 2023 | 122,000 | -11,746,000 | -11,706,000 | 3,355,000 | 91,790,000 | -88,984,000 | -7,402,000 |
| Dec 2022 | 2,029,000 | -16,685,000 | -17,215,000 | 11,852,000 | 87,586,000 | -76,283,000 | -8,952,000 |
TTM Snapshot
Revenues TTM
$37,000
NetIncome TTM
$-33,000
OpCashFlow TTM
—
Assets (Latest)
$6,865,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VIVS | VivoSim Labs, INC. | $2.37M | $0.18 | — |
| CRIS | CURIS INC | $1.72M | $0.71 | — |
| BCAB | BioAtla, Inc. | $2.63M | $1.58 | — |
| CLDI | Calidi Biotherapeutics, Inc. | $2.69M | $1.04 | — |
| SLXN | Silexion Therapeutics Corp | $1.31M | $0.23 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.